Results 201 to 210 of about 1,013,409 (346)

Harmonizing Innovations: An In-Depth Comparative Review on the Formulation, Applications, and Future Perspectives of Aerogels and Hydrogels in Pharmaceutical Sciences. [PDF]

Gels
Alaghawani NA, Alkhatib H, Elmancy L, Daou A.   +3 more
europepmc   +1 more source

The Nationwide Research of Communication Educate Curriculum in the Faculty of Pharmaceutical Science —The Second Report: The Study of Communication Educate Curriculum before On-the-job Training—

, 2004
Etsuko Arita, Mika HOSOYA, Hiromi IKETANI, Tomomi Iioka, Naoko Ideguchi, Yoshiko Ogawa, Keiko Goto, Kenshi Yoshida   +7 more
openalex   +2 more sources

Clinical Outcomes Of Patients Within The Rheumatoid Arthritis Care Pathway Cohort At a Tertiary Care Integrated Delivery Network: A Comparison To Usual Care

Arthritis Care &Research, Accepted Article.
Objective We aimed to compare clinical outcomes between patients in the Allegheny Health Network rheumatoid arthritis (RA) care pathway and patients receiving usual care. Methods The care pathway initiative implements guideline‐based best practice alongside multi‐disciplinary team‐based care. Clinical and insurance claims data were extracted to compare
Tarun Sharma, Tyson S. Barrett, Teigan Dwyer, Nancy Campbell, Jessica Heintzinger, Ellen Kraemer, Adam Dore, Susan Manzi   +7 more
wiley   +1 more source

Advancements and Applications of Artificial Intelligence in Pharmaceutical Sciences: A Comprehensive Review. [PDF]

Iran J Pharm Res
Mottaghi-Dastjerdi N, Soltany-Rezaee-Rad M.   +1 more
europepmc   +1 more source

Open Systems Pharmacology Community-An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences. [PDF]

CPT Pharmacometrics Syst Pharmacol, 2019
Lippert J, Burghaus R, Edginton A, Frechen S, Karlsson M, Kovar A, Lehr T, Milligan P, Nock V, Ramusovic S, Riggs M, Schaller S, Schlender J, Schmidt S, Sevestre M, Sjögren E, Solodenko J, Staab A, Teutonico D.   +18 more
europepmc   +1 more source

Temporal trends in and associations with nonsteroidal anti‐inflammatory drug prescription in adult and pediatric patients with inflammatory bowel disease

Arthritis Care &Research, Accepted Article.
Objective Recent inflammatory bowel disease (IBD) treatment guidelines have recommended against NSAID use despite prevalent musculoskeletal symptoms and opioid overuse in this population. Given the discordance between changing national guidelines and potential clinical utility, we sought to assess national temporal trends in prescription NSAID and ...
Adam S. Mayer, Rui Xiao, Andrew Grossman, Meenakshi Bewtra, Michael D. George, Pamela F. Weiss   +5 more
wiley   +1 more source

Can they imagine the future? A qualitative study exploring the skills employers seek in pharmaceutical sciences doctoral graduates. [PDF]

PLoS One, 2019
McLaughlin JE, Minshew LM, Gonzalez D, Lamb K, Klus NJ, Aubé J, Cox W, Brouwer KLR.   +7 more
europepmc   +1 more source

A Survey of the Levels of Satisfaction with Pharmacy Practice on the Third-year Students in Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido

, 2005
Michiya Kobayashi, Masako Oda, Hiroshi Saitoh   +2 more
openalex   +2 more sources

The Role of Entrepreneurial Activities in Academic Pharmaceutical Science Research [PDF]

, 2009
Audra L. Stinchcomb
openalex   +1 more source

Serum soluble mediator signatures of lupus nephritis: histological features and response to treatment

Arthritis Care &Research, Accepted Article.
Objective Lupus nephritis (LN) management remains challenging, and novel noninvasive biomarkers are needed. This study quantified serum soluble mediators in the Accelerating Medicines Partnership (AMP) LN cohort to identify biomarkers of histological features and treatment response.
Andrea Fava, Catriona A. Wagner, Carla J. Guthridge, Susan Macwana, Wade DeJager, Melissa E. Munroe, Peter Izmirly, H. Michael Belmont, Betty Diamond, Anne Davidson, Paul J. Utz, Michael H Weisman, Philip M Carlucci, Maria Dall'Era, Kenneth Kalunian, Chaim Putterman, Jennifer Anolik, Jennifer L Barnas, David Wofsy, Diane Kamen, Richard A Furie, Deepak A Rao, the Accelerating Medicines Partnership (AMP) RA/SLE Network, Michelle Petri, Joel M. Guthridge, Jill Buyon, Judith A. James   +26 more
wiley   +1 more source